Center for Substance Abuse Prevention; Notice of Meeting, 48169 [05-16165]

Download as PDF 48169 Federal Register / Vol. 70, No. 157 / Tuesday, August 16, 2005 / Notices facilities serving adults and those serving children and/or adolescents, with various subgroups such as forensic and sexual offender populations. With input from multiple experts in the field of restraint and seclusion and alternatives to restraint and seclusion, the project created a common core of data collection instruments that will be used for this cross-site project. The facilities will complete four different instruments: (1) Facility/Program Characteristics Inventory (information about type of facilities, characteristics of persons served, staffing patterns, and unit specific data); (2) Inventory of Seclusion and Restraint Reduction Interventions; (3) Treatment Episode Data (admission data for all clients/ patients); and (4) Event Data (data about the use of restraint and seclusion). Data will be submitted by the sites electronically via a secured Web site. The Facility/Program Characteristic Inventory and Inventory of Seclusion and Restraint Reduction Intervention will be collected annually. The Treatment Episode Data and Event Data will be collected monthly. The resulting data will help to identify the: (1) Number of programs adopting best practices involving alternative approaches to restraint and seclusion; and (2) program’s impact of reducing restraint and seclusion use and adoption of alternative practices. The estimated annual response burden to collect this information is as follows: Number of respondents Instrument Responses/ respondent Burden/ response (hours) Annual burden (hours) Facility/Program Characteristic Inventory ........................................................ Inventory of Seclusion and Restraint Reduction Interventions ....................... Treatment Episode Data .................................................................................. Event Data ....................................................................................................... 49 49 49 49 1 1 12 12 4 2 8 8 196 98 4,704 4,704 Total .......................................................................................................... 49 ........................ ........................ 9,702 Written comments and recommendations concerning the proposed information collection should be sent by September 15, 2005 to: SAMHSA Desk Officer, Human Resources and Housing Branch, Office of Management and Budget, New Executive Office Building, Room 10235, Washington, DC 20503; due to potential delays in OMB’s receipt and processing of mail sent through the U.S. Postal Service, respondents are encouraged to submit comments by fax to: 202–395– 6974. Dated: August 9, 2005. Anna Marsh, Executive Officer, SAMHSA. [FR Doc. 05–16179 Filed 8–15–05; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Pub. L. 92–463, notice is hereby given of the meeting of the Substance Abuse and Mental Health Services Administration (SAMHSA) Drug Testing Advisory Board on September 7–8, 2005. A portion of the meeting will be open and will include a roll call, general announcements, a Department of Health and Human Services drug testing program update, a Department of Transportation drug testing program update, and a Nuclear Regulatory VerDate jul<14>2003 18:02 Aug 15, 2005 Jkt 205001 Commission drug testing program update. Attendance by the public will be limited to space available. Public comments are welcome. Please communicate with the individual listed below as contact to make arrangements to comment or to request special accommodations for persons with disabilities. The Board will also meet to develop the analytical and administrative policies for the final revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Program that were published as proposed revisions in the Federal Register on April 13, 2004 (69 FR 19673). The submissions from 285 commenters have been made available to the public on the Web site http://workplace.samhsa.gov. This meeting will be conducted in closed session since discussing such public comments in open session and then developing the policies will significantly frustrate the Department’s ability to develop the final notice of revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs. The HHS Office of General Counsel made the determination that such matters are protected by exemption 9(B) of section 552b(c) of title 5 U.S.C. and therefore may be closed to the public. Substantive program information and a roster of Board members may be obtained by accessing the SAMHSA workplace Web site (http:// workplace.samhsa.gov) or communicating with the contact whose name and telephone number are listed below. The transcript for the open session will be available on the PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 SAMHSA workplace Web site as soon as possible after the meeting. Committee Name: Substance Abuse and Mental Health Services Administration Drug Testing Advisory Board. Meeting Date: September 7–8, 2005. Place: Residence Inn by Marriott, 7335 Wisconsin Avenue, Bethesda, Maryland 20814. Type: Open: September 7, 2005; 8:30 a.m.– 9:30 a.m. Closed: September 7, 2005; 9:30 a.m.–4:30 p.m. Closed: September 8, 2005; 8:30 a.m.– Noon. Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry Road, Room 2– 1033, Rockville, Maryland 20857, 240–276– 2600 (telephone) and 240–276–2610 (fax), email: Donna.Bush@samhsa.hhs.gov. Dated: August 9, 2005. Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health Services Administration. [FR Doc. 05–16165 Filed 8–15–05; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of a Teleconference Meeting of the Center for Substance Abuse Treatment (CSAT) National Advisory Council to be held in September 2005. The meeting will include the review, discussion and evaluation of grant E:\FR\FM\16AUN1.SGM 16AUN1

Agencies

[Federal Register Volume 70, Number 157 (Tuesday, August 16, 2005)]
[Notices]
[Page 48169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16165]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the Substance Abuse and Mental Health Services Administration 
(SAMHSA) Drug Testing Advisory Board on September 7-8, 2005.
    A portion of the meeting will be open and will include a roll call, 
general announcements, a Department of Health and Human Services drug 
testing program update, a Department of Transportation drug testing 
program update, and a Nuclear Regulatory Commission drug testing 
program update.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with the individual listed 
below as contact to make arrangements to comment or to request special 
accommodations for persons with disabilities.
    The Board will also meet to develop the analytical and 
administrative policies for the final revisions to the Mandatory 
Guidelines for Federal Workplace Drug Testing Program that were 
published as proposed revisions in the Federal Register on April 13, 
2004 (69 FR 19673). The submissions from 285 commenters have been made 
available to the public on the Web site http://workplace.samhsa.gov. 
This meeting will be conducted in closed session since discussing such 
public comments in open session and then developing the policies will 
significantly frustrate the Department's ability to develop the final 
notice of revisions to the Mandatory Guidelines for Federal Workplace 
Drug Testing Programs. The HHS Office of General Counsel made the 
determination that such matters are protected by exemption 9(B) of 
section 552b(c) of title 5 U.S.C. and therefore may be closed to the 
public.
    Substantive program information and a roster of Board members may 
be obtained by accessing the SAMHSA workplace Web site (http://
workplace.samhsa.gov) or communicating with the contact whose name and 
telephone number are listed below. The transcript for the open session 
will be available on the SAMHSA workplace Web site as soon as possible 
after the meeting.

    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Meeting Date: September 7-8, 2005.
    Place: Residence Inn by Marriott, 7335 Wisconsin Avenue, 
Bethesda, Maryland 20814.
    Type: Open: September 7, 2005; 8:30 a.m.-9:30 a.m.
    Closed: September 7, 2005; 9:30 a.m.-4:30 p.m.
    Closed: September 8, 2005; 8:30 a.m.-Noon.
    Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke 
Cherry Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 
(telephone) and 240-276-2610 (fax), e-mail: 
Donna.Bush@samhsa.hhs.gov.

    Dated: August 9, 2005.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 05-16165 Filed 8-15-05; 8:45 am]
BILLING CODE 4162-20-P